
Codis appoints Steven Facer as chief commercial officer
pharmafile | September 21, 2026 | Appointment | |Â Â CodisÂ
Codis has appointed Steven Facer as Chief Commercial Officer (CCO) in a newly created role as the contract development and manufacturing organisation (CDMO) expands its commercial operations.
Facer will oversee Sales, Marketing and Business Development, with responsibility for aligning the functions across the company’s US and UK operations.
He joined Codis in October 2025 and has more than 30 years’ experience across the pharmaceutical, medical device and packaging sectors.
His previous senior executive roles include positions at Thermo Fisher Scientific, ACG Worldwide, Capsugel, Catalent, Colorcon and Adare Pharma Solutions.
Codis CEO Nicolas Fortin said Facer would shape the company’s commercial strategy and strengthen collaboration across regions.
The appointment is part of Codis’s move towards a unified commercial organisation spanning its spray drying, amorphous solid dispersion and particle engineering activities.






